https://www.excelra.com/blogs/coronavirus-clinical-trials-landscape-analysis-using-excelras-covid-19-biomarker-database/2026-04-22T15:55:38+00:00https://www.excelra.com/blogs/biologics-the-biotech-drugs-transforming-medicine-2/2026-04-23T07:50:50+00:00https://www.excelra.com/blogs/data-curation-for-model-based-meta-analysis-mbma-an-integral-part-of-mid3/2026-04-23T07:50:36+00:00https://www.excelra.com/blogs/data-driven-drug-repurposing/2026-04-23T07:50:22+00:00https://www.excelra.com/blogs/data-in-healthcare-how-far-we-have-come/2026-04-22T15:53:55+00:00https://www.excelra.com/blogs/digitization-data-science-in-drug-discovery/2026-04-22T15:53:37+00:00https://www.excelra.com/blogs/drug-target-dossier-target-intelligence-for-data-driven-drug-discovery/2026-04-23T07:50:09+00:00https://www.excelra.com/blogs/empowering-drug-discovery-with-big-data-and-artificial-intelligence/2026-04-22T15:52:46+00:00https://www.excelra.com/blogs/fairification-a-path-to-scientific-data-connectivity/2026-04-22T15:52:29+00:00https://www.excelra.com/blogs/gobiom-understanding-the-platforms-utility-in-clinical-research-and-drug-development/2026-04-22T15:51:56+00:00https://www.excelra.com/blogs/gobioms-biomarker-database-for-enabling-precision-medicine/2026-04-22T15:51:34+00:00https://www.excelra.com/blogs/gostar-the-largest-online-medicinal-chemistry-intelligence-database/2026-04-22T15:51:12+00:00https://www.excelra.com/blogs/g-protein-coupled-receptors-structures-research-landscape-and-trends/2026-04-23T07:49:38+00:00https://www.excelra.com/blogs/integrated-text-mining-data-curation-approaches-for-biomedical-knowledgebase-development/2026-04-23T07:49:21+00:00https://www.excelra.com/blogs/interview-with-anandbir-singh-brar-chief-executive-officer-excelra/2026-04-23T07:49:12+00:00https://www.excelra.com/blogs/key-aspects-of-building-a-predictive-analytics-engine/2026-05-19T04:44:55+00:00https://www.excelra.com/blogs/immunostimulation-a-key-driver-to-combat-coronavirus/2026-04-23T07:49:01+00:00https://www.excelra.com/blogs/pivotal-role-of-biomarkers-in-diagnosing-the-ever-changing-landscape-of-covid-19-infection/2026-04-22T15:56:19+00:00https://www.excelra.com/blogs/repurposed-drugs-for-covid-19/2026-04-23T07:48:42+00:00https://www.excelra.com/blogs/semantic-metadata-catalog-for-metadata-management/2026-04-22T15:46:46+00:00https://www.excelra.com/blogs/life-sciences-tech-trends-2021/2026-04-22T15:55:59+00:00https://www.excelra.com/blogs/using-legacy-and-current-data-to-accelerate-drug-development/2026-05-19T04:26:06+00:00https://www.excelra.com/blogs/ontologies-and-the-fair-data-principles/2026-04-22T15:44:37+00:00https://www.excelra.com/news/excelra-proofpilot-investment/2026-03-05T06:47:28+00:00https://www.excelra.com/news/excelra-partners-with-patcore/2026-01-18T07:30:59+00:00https://www.excelra.com/news/excelra-partners-with-hotspot-therapeutics-to-enhance-allosteric-drug-discovery-efforts/2026-01-18T07:35:12+00:00https://www.excelra.com/news/excelra-makes-strategic-investment-in-anlitiks-a-disruptive-heor-and-rwe-technology-led-consulting-company/2026-01-18T07:36:19+00:00https://www.excelra.com/news/x-chem-and-excelra-gostar-join-forces/2026-01-18T07:38:34+00:00https://www.excelra.com/news/xtalpi-partners-with-excelra/2026-01-18T07:39:37+00:00https://www.excelra.com/news/silexon-partners-with-excelra/2025-07-17T04:24:51+00:00https://www.excelra.com/news/excelra-announces-addition-of-sudip-nandy-to-its-board-of-directors/2026-01-18T07:40:38+00:00https://www.excelra.com/news/excelra-launches-a-re-envisioned-version-of-gostar-its-structure-activity-relationship-application/2026-05-22T08:05:24+00:00https://www.excelra.com/news/cyclica-to-use-excelras-gostar-database-to-develop-ai-ml-based-deep-learning-algorithm-for-drug-target-identification/2026-01-18T14:17:30+00:00https://www.excelra.com/news/interview-with-anandbir-brar-chief-executive-officer-excelra-headline-partner-at-d4-global-virtual-event/2026-03-10T10:20:18+00:00https://www.excelra.com/news/standigm-partners-with-excelra-for-gostar-to-enhance-its-ai-driven-drug-discovery-process/2026-01-18T14:18:27+00:00https://www.excelra.com/news/excelra-keio-drugrepurposing-collaboration/2026-03-05T13:54:42+00:00https://www.excelra.com/news/excelra-maruho-drugrepurposing-collaboration/2026-01-18T07:51:04+00:00https://www.excelra.com/news/excelra-expands-its-drug-repurposing-solutions-outreach-in-europe-through-collaboration-with-h-m-pharma-consultancy/2026-03-10T05:13:45+00:00https://www.excelra.com/news/excelra-iit-kharagpur/2026-01-18T07:52:42+00:00https://www.excelra.com/news/california-institute/2026-01-18T06:47:18+00:00https://www.excelra.com/news/frost-sullivan/2026-01-18T06:49:59+00:00https://www.excelra.com/news/interview-with-nandu-gattu/2026-01-18T06:51:48+00:00https://www.excelra.com/news/astellas-pharma/2026-01-18T06:52:36+00:00https://www.excelra.com/whitepaper/optimizing-preclinical-toxicology-data-analysis/2026-03-06T05:53:13+00:00https://www.excelra.com/whitepaper/accelerated-drug-repurposing-using-advanced-analytics/2026-01-23T06:05:14+00:00https://www.excelra.com/whitepaper/training-machine-learning-algorithms-on-different-data-scales/2026-04-22T17:36:33+00:00https://www.excelra.com/whitepaper/accelerating-discovery-and-creating-value/2026-01-23T05:21:22+00:00https://www.excelra.com/blogs/bringing-data-to-life-with-kols/2026-04-23T07:48:20+00:00https://www.excelra.com/blogs/the-impact-of-key-opinion-leaders-kols/2026-04-23T07:48:33+00:00https://www.excelra.com/blogs/why-you-need-key-opinion-leaders-kols-in-your-medical-device-marketing-strategy/2026-04-22T15:44:13+00:00https://www.excelra.com/blogs/analysis-ready-clinical-datasets/2026-04-23T07:47:44+00:00https://www.excelra.com/whitepaper/optimizing-sc-rna-seq-data-analysis-with-effective-pipeline-development/2026-03-06T06:01:17+00:00https://www.excelra.com/blogs/choosing-ontology-management-system/2026-04-22T15:43:22+00:00https://www.excelra.com/blogs/role-of-key-opinion-leaders-in-accelerating-covid-19-vaccine/2026-04-23T07:47:36+00:00https://www.excelra.com/whitepaper/selecting-and-preparing-data-for-ai-ml-predictive-modeling/2026-04-22T17:36:21+00:00https://www.excelra.com/blogs/a-day-in-the-life-of-a-clinical-pharmacology-expert/2026-04-23T07:47:28+00:00https://www.excelra.com/blogs/gostar-vs-chembl/2026-04-22T15:42:17+00:00https://www.excelra.com/whitepaper/disease-landscapes-scientific-strategic-assessemment-for-drug-development/2026-03-06T05:44:52+00:00https://www.excelra.com/news/excelra-acquires-bisc-global/2026-03-05T14:24:59+00:00https://www.excelra.com/blogs/significance-of-quantitative-techniques-for-drug-attrition/2026-04-23T07:47:18+00:00https://www.excelra.com/blogs/how-is-machine-learning-changing-flow-cytometry-data-analysis/2026-04-22T15:41:16+00:00https://www.excelra.com/blogs/public-data-repositories-biobanks-or-commercial-data-providers/2026-04-23T07:47:10+00:00https://www.excelra.com/blogs/cloud-based-computing-environment-for-biotech-start-ups/2026-04-22T15:40:50+00:00https://www.excelra.com/blogs/4-major-bioinformatics-expertise-sources-for-biotech-start-ups/2026-04-22T15:40:26+00:00https://www.excelra.com/publications/altered-dna-methylation/2026-01-18T07:17:46+00:00https://www.excelra.com/publications/dynamics-of-the-magnitude-breadth-and-depth-of-the-antibody-response/2026-01-18T07:17:06+00:00https://www.excelra.com/blogs/gostar-updates-the-latest-feature-enhancements/2026-04-22T15:40:06+00:00https://www.excelra.com/news/bisc-global-receives-half-a-million-euros/2026-01-18T07:21:27+00:00https://www.excelra.com/news/bisc-global-awarded-a-eurostars-grant/2026-01-18T07:43:25+00:00https://www.excelra.com/news/bisc-global-selected-as-top-10-bioinformatics-company-by-cio-applications/2026-01-18T07:46:06+00:00https://www.excelra.com/uncategorized/merck-tech-symposium/2026-01-18T06:43:01+00:00https://www.excelra.com/blogs/types-of-drug-discovery-databases/2026-04-23T07:47:00+00:00https://www.excelra.com/blogs/analyzer-in-gostar-interactive-property-space-exploration/2026-04-22T15:39:15+00:00https://www.excelra.com/blogs/analyzer-in-gostar-matched-molecular-pair-analysis/2026-04-22T15:38:53+00:00https://www.excelra.com/blogs/analyzer-in-gostar-the-drug-target-interaction-heatmap/2026-04-22T15:38:35+00:00https://www.excelra.com/blogs/from-clutter-to-clarity-the-essential-guide-to-eln-and-lims/2026-04-22T15:38:09+00:00https://www.excelra.com/blogs/exploring-new-frontiers-clinical-pharmacology-in-modern-drug-development/2026-05-19T04:51:23+00:00https://www.excelra.com/whitepaper/biomarker-discovery-qualification-validity-index/2026-03-06T05:55:23+00:00https://www.excelra.com/whitepaper/roadmap-to-biomarker-discovery-innovations-opportunities-and-breakthroughs/2026-03-06T05:55:24+00:00https://www.excelra.com/whitepaper/identifying-druggable-therapeutic-targets-unveiling-promising-avenues-in-drug-discovery/2026-03-06T05:55:27+00:00https://www.excelra.com/blogs/will-leveraging-eln-lims-consultancy-services-improve-efficiency-and-precision/2026-04-22T15:37:25+00:00https://www.excelra.com/blogs/improving-target-selection-validation-role-of-qsp/2026-05-19T04:50:25+00:00https://www.excelra.com/blogs/the-importance-of-data-visualization-in-the-pharmaceutical-industry/2026-04-22T15:36:06+00:00https://www.excelra.com/publications/codd-pred-a-web-server-for-efficient-target-identification-and-bioactivity-prediction-of-small-molecules/2026-01-18T07:14:53+00:00https://www.excelra.com/publications/a-blueprint-for-high-affinity-sars-cov-2-mpro-inhibitors-from-activity-based-compound-library-screening-guided-by-analysis-of-protein-dynamics/2026-01-18T07:14:16+00:00https://www.excelra.com/publications/paclitaxel-activates-c5a-r1-chemotherapy-neuropathy/2026-02-20T10:00:10+00:00https://www.excelra.com/publications/generative-molecular-design-and-experimental-validation-of-selective-histamine-h1-inhibitors/2026-05-22T14:18:04+00:00https://www.excelra.com/blogs/decoding-lifes-blueprint-the-power-of-dna-sequence-analysis-in-bioinformatics/2026-05-19T04:52:18+00:00https://www.excelra.com/blogs/unravelling-the-path-to-drug-discovery-through-cheminformatics/2026-05-19T04:26:57+00:00https://www.excelra.com/blogs/bioinformatics-solutions-tools-and-techniques-for-data-driven-discoveries/2026-05-19T04:53:18+00:00https://www.excelra.com/blogs/an-introduction-to-business-consulting-and-scientific-advice-in-lab-informatics/2026-04-22T15:33:14+00:00https://www.excelra.com/publications/computational-drug-discovery-methods-and-applications/2026-01-18T07:10:39+00:00https://www.excelra.com/news/excelra-certified-for-third-consecutive-year-great-place-to-work/2025-07-22T17:04:41+00:00https://www.excelra.com/publications/biomarkers-the-key-to-early-cancer-detection-and-patient-outcomes/2024-11-18T10:45:20+00:00https://www.excelra.com/whitepaper/breaking-barriers-decoding-innovative-strategies-for-functional-proteomics-in-drug-discovery-and-development/2026-03-06T06:00:55+00:00https://www.excelra.com/blogs/introduction-to-continuous-support-and-maintenance/2026-04-22T15:32:54+00:00https://www.excelra.com/blogs/going-digital-emerging-potential-of-digital-biomarkers-and-ai-ml-in-healthcare/2026-04-27T07:30:28+00:00https://www.excelra.com/blogs/eln-lims-master-data-preparation-building-the-foundation-for-data-excellence/2026-04-23T07:45:40+00:00https://www.excelra.com/blogs/modernize-your-lab-migration-integrations-and-custom-app-development/2026-04-22T15:30:04+00:00https://www.excelra.com/blogs/biomarker-landscape-analysis-unveiling-challenges-and-opportunities/2026-04-22T15:29:42+00:00https://www.excelra.com/blogs/lab-informatics-implementation-and-delivery/2026-04-22T15:29:18+00:00https://www.excelra.com/blogs/maximize-your-eln-lims-investment-with-managed-services-for-life-sciences/2026-04-22T15:28:50+00:00https://www.excelra.com/publications/alpha-synuclein-aggregation-cellular-proteostasis-parkinsons-disease/2026-01-18T07:08:17+00:00https://www.excelra.com/blogs/rag-content-creation-benefits/2026-04-22T15:23:54+00:00https://www.excelra.com/blogs/biomedical-data-asset-creation-challenges/2026-04-22T15:28:06+00:00https://www.excelra.com/publications/proboscis-bat-genome-sequencing/2026-01-18T07:05:50+00:00https://www.excelra.com/publications/dapagliflozin-ldl-cholesterol-type-2-diabetes/2026-01-18T07:04:39+00:00https://www.excelra.com/blogs/data-transformation-scientific-research/2026-04-23T07:45:05+00:00https://www.excelra.com/blogs/modular-ai-enhancing-efficiency-and-impact-in-life-sciences/2026-04-22T15:26:22+00:00https://www.excelra.com/blogs/lipid-nanoparticle-development-ai-data-driven-approaches/2026-04-22T15:25:46+00:00https://www.excelra.com/blogs/troubleshooting-amazon-sagemaker-pipelines/2026-04-22T15:25:13+00:00https://www.excelra.com/blogs/excelra-gostar-eu-compliance-pharmaceutical-research/2026-04-23T07:44:45+00:00https://www.excelra.com/blogs/ai-data-analytics-precision-medicine/2026-04-22T15:24:18+00:00https://www.excelra.com/blogs/predicting-caco-2-permeability-gostar-vs-benchmarking-dataset/2026-04-22T15:23:16+00:00https://www.excelra.com/whitepaper/excelra-spatial-transcriptomics-solutions/2026-03-06T05:52:29+00:00https://www.excelra.com/blogs/biovisualizer-mirna-data-visualization-tool/2026-04-22T15:18:19+00:00https://www.excelra.com/whitepaper/unstructured-data-life-sciences-ace/2026-03-06T06:01:08+00:00https://www.excelra.com/whitepaper/omics-data-a-biomedical-asset-driving-the-future-of-drug-discovery-and-development/2026-03-06T06:00:17+00:00https://www.excelra.com/news/excelra-orogen-therapeutics-partnership-ai-drug-discovery/2026-03-25T07:31:21+00:00https://www.excelra.com/whitepaper/ai-ml-medical-imaging-cancer-diagnosis-treatment/2026-01-12T09:37:20+00:00https://www.excelra.com/blogs/10x-visium-a-breakthrough-enabling-omics-analysis-at-spatial-level/2026-04-22T15:17:54+00:00https://www.excelra.com/blogs/u-net-becoming-the-foundation-of-modern-biomedical-image-segmentation-models/2026-05-22T08:21:31+00:00https://www.excelra.com/publications/fgfr3-alterations-asian-bladder-cancer/2026-01-18T06:41:00+00:00https://www.excelra.com/blogs/walkthrough-of-targeted-protein-degradation/2026-04-22T11:31:39+00:00https://www.excelra.com/blogs/genomic-alterations-precision-medicine-bladder-cancer/2026-04-22T11:31:10+00:00https://www.excelra.com/news/gostar-sar-database-now-faster-smarter-and-more-efficient/2025-12-09T08:46:30+00:00https://www.excelra.com/news/asedasciences-partners-with-excelra-for-gostar/2026-01-18T06:58:39+00:00https://www.excelra.com/whitepaper/drug-development-preclinical-data/2026-03-06T05:52:24+00:00https://www.excelra.com/blogs/data-into-personalized-therapies/2026-04-22T11:30:41+00:00https://www.excelra.com/blogs/training-your-algorithms/2026-04-22T11:30:27+00:00https://www.excelra.com/blogs/eln-lims-ideal-system/2026-04-22T11:29:50+00:00https://www.excelra.com/blogs/revvity-lab-efficiency-tools/2026-04-22T11:29:20+00:00https://www.excelra.com/blogs/consulting-scientific-informatics-partners/2026-05-22T09:16:26+00:00https://www.excelra.com/whitepaper/ai-antibody-discovery-workflow/2026-03-06T06:00:17+00:00https://www.excelra.com/whitepaper/biovisualizer-data-analysis-platform/2026-03-06T05:59:36+00:00https://www.excelra.com/blogs/bioinformatics-workflow-managers/2026-04-27T07:23:16+00:00https://www.excelra.com/blogs/eln-lims-integration-benefits/2026-04-27T07:25:07+00:00https://www.excelra.com/blogs/eln-lims-strategy-success/2026-05-22T14:15:31+00:00https://www.excelra.com/blogs/scaffold-analysis-gostar-tpd/2026-04-22T11:27:13+00:00https://www.excelra.com/news/new-degraders-gostar-tpd/2026-01-18T06:55:09+00:00https://www.excelra.com/blogs/digitalization-sirna-oligo-therapeutics/2026-04-27T07:26:10+00:00https://www.excelra.com/publications/race-related-host-microbe-signatures/2026-01-18T06:53:43+00:00https://www.excelra.com/whitepaper/data-readiness-ai-pharma-biotech/2026-05-06T05:54:52+00:00https://www.excelra.com/blogs/ai-agents-life-sciences/2026-04-27T07:21:56+00:00https://www.excelra.com/whitepaper/fair-data-in-biopharma/2026-03-06T05:49:07+00:00https://www.excelra.com/blogs/cro-data-standardisation/2026-04-27T07:28:52+00:00https://www.excelra.com/whitepaper/journey-of-a-small-molecule/2026-04-22T17:36:07+00:00https://www.excelra.com/blogs/innersource-in-bioinformatics-data-interpretation-collaboration/2026-05-22T14:52:18+00:00https://www.excelra.com/blogs/data-landscape-assessment-digital-transformation-pharma/2026-04-27T07:26:59+00:00https://www.excelra.com/news/gostar-small-molecules-update-2025/2026-02-13T05:05:22+00:00https://www.excelra.com/blogs/ai-lab-informatics-automating-synthesis-workflows/2026-04-22T11:24:23+00:00https://www.excelra.com/blogs/ai-driven-adam-r-code-automation/2026-04-22T11:23:59+00:00https://www.excelra.com/blogs/data-lake-vs-data-mesh-architecture/2026-04-22T11:23:32+00:00https://www.excelra.com/blogs/data-governance-trusted-ai/2026-04-23T07:43:10+00:00https://www.excelra.com/blogs/reusable-protocols-in-dotmatics/2026-04-22T11:22:22+00:00https://www.excelra.com/blogs/human-in-the-loop-autonomous-labs/2026-04-22T11:21:53+00:00https://www.excelra.com/blogs/patent-intelligence-drug-discovery-gostar/2026-04-22T17:08:53+00:00https://www.excelra.com/whitepaper/pk-metadata-extraction-nlp-ddi/2026-05-20T06:17:51+00:00https://www.excelra.com/blogs/lab-data-quality-life-sciences/2026-04-22T17:33:44+00:00https://www.excelra.com/blogs/clinical-data-extraction-in-pharma-ai-automation/2026-05-26T09:02:43+00:00https://www.excelra.com/blogs/why-pharma-ai-depends-on-data-foundations/2026-06-01T04:57:13+00:00